What are the requirements for using iPledge?

The iPledge Program is designed to ensure the safe usage of isotretinoin, an effective medication for severe acne. Participation in the program requires adherence to several specific guidelines, which primarily focus on preventing pregnancy due to the high risk associated with the drug. First and foremost, individuals using isotretinoin must be enrolled in the iPledge System. This involves registering and providing necessary personal information. For females of childbearing age, there are additional stringent precautions. These individuals must demonstrate that they are not pregnant prior to starting the medication and must utilize two forms of effective contraception during treatment and for a period afterward. This dual contraceptive requirement is crucial, given the potential teratogenic effects of isotretinoin. Furthermore, both male and female patients must agree to comply with the program requirements and follow their healthcare provider's guidelines closely. Regular follow-up appointments with a healthcare professional are required for monitoring the patient's health and ensuring adherence to iPledge protocols. During these appointments, patients may need to undergo laboratory tests to assess their health status, including liver function tests and lipid levels. If you are considering using isotretinoin or have questions about enrolling in the iPledge Program, it may be beneficial to review the details on the current web page or consult your healthcare provider to ensure you fully understand all requirements and procedures involved.